Bluesight aims efficiency with redesigned 340BCheck platform. AI Summary % buffered Bluesight has introduced a fully redesigned 340BCheck platform, describing it as a compliance command center created to support covered entities in maintaining compliance standards and protecting their 340B programs. The updated software expands upon technology initially developed by Sectyr and later acquired by Bluesight in 2024. Following the acquisition, the company broadened the platform's functionality, including the addition of a 100% transaction audit in 2025, before unveiling the newly redesigned interface. The redesigned 340BCheck platform incorporates Bluesight's workflow-driven design together with core compliance infrastructure. The platform includes a wide range of current and planned capabilities, such as full transaction auditing across patient, provider, and location definitions, OPAIS database synchronization, contract pharmacy and pharmacy service agreement management, Medicare cost report maintenance, Medicaid exclusion file validation, policy and procedure management, mock HRSA audits, as well as integrated documentation and task management. The launch arrives during what the company described as a difficult period for the 340B program, which has become increasingly important to the financial stability of healthcare organizations. During fiscal year 2025, HRSA audited 115 covered entities, with nearly half receiving adverse findings. Incorrect OPAIS records were identified in 75% of those audited entities, reinforcing the need for broader compliance infrastructure beyond transaction-level auditing alone. At the same time, healthcare organizations are managing evolving manufacturer data-sharing demands, ongoing discussions around rebate-based distribution models from HRSA, and changing contract pharmacy disputes occurring at the state level. As compliance expectations continue to grow, covered entities are facing significantly greater regulatory and documentation burdens while often relying on the same operational teams they had several years ago. Many organizations are also simultaneously expanding their 340B programs, contributing to a rising number of auditable transactions. Bluesight said the redesigned 340BCheck platform was built specifically to help covered entities remain continuously prepared for HRSA audits. According to the company, the workflows were structured around actual HRSA audit requirements, beginning with the standards necessary for a successful audit and then moving on to provide workflows designed to support continuous audit readiness. The updated system builds on years of operational experience among 340B program teams while introducing a faster and more intuitive interface. "340B compliance used to be about spot checks, but today it's about continuous readiness," noted Kevin MacDonald. "Audit scrutiny is rising, manufacturer requirements are expanding, and a potential rebate model could add entirely new documentation layers - without any increase in team size for most organizations. Covered entities should be audit-ready every single day, not just when HRSA shows up." The redesigned 340BCheck platform was previewed at both ASHP Midyear in December 2025 and the 340B Coalition Annual Conference in February 2026, where program managers responded positively to its emphasis on continuous compliance coverage. Bluesight also stated that it is developing additional capabilities designed for a rebate-based pricing model inside the 340B program, including tools supporting procurement decisions, aligning 340B transaction audits with rebate-eligible transactions, and rebate payment tracking. Bluesight uses intelligence to power hospital operations, making procurement, compliance, and inventory management simpler. Bluesight guarantees that health systems safeguard every patient and maximise every dollar with its array of industry-leading technologies. Every day, more than 3,000 hospitals in the US and Canada depend on Bluesight for effective and secure operations. The pharmaceutical industry rarely announces its most significant shifts loudly. The signals are there - if you know where to look. The Pharma Advancement briefing is how the sector's most informed professionals stay ahead of those signals - covering drug development, regulatory affairs, manufacturing, and market access across every major region. * The stories pharmaceutical professionals will be discussing tomorrow, in your inbox today * Analysis that goes beyond the headline - written for readers who already understand the industry * The briefing that the sector's most informed professionals open first

Bluesight expands access to solutions through strategic partnership with Pharma Logistics. By Adam Rosenberg Health System Pharmacies Can Leverage Value Uncovered Through Reverse Distribution Services to Purchase Bluesight Solutions ALEXANDRIA, Va., April 22, 2026 - Bluesight, the leader in hospital intelligence solutions, formally announced a strategic partnership with Pharma Logistics, a leading provider of pharmaceutical reverse distribution services. This collaboration introduces an innovative financing model that allows healthcare systems to utilize their medication return credits to invest in Bluesight's full suite of technology solutions. As hospitals and health systems face escalating financial pressures, the partnership addresses the critical need for capital solutions. By leveraging the value recovered from unused and expired medications, pharmacy leaders now have an alternative means of acquiring technology that enhances patient safety and operational efficiency. Turning Recovered Value into Innovation Through this partnership, healthcare organizations that utilize Pharma Logistics for their pharmaceutical returns can apply their accrued credits directly toward the purchase of any Bluesight product, including: CostCheck, ControlCheck, KitCheck, ShortageCheck, 340BCheck, and PrivacyPro. "Our mission has always been to empower pharmacy teams with the tools they need to operate safely and efficiently," said Kevin MacDonald, CEO and Co-founder at Bluesight. "By partnering with Pharma Logistics, we are improving access to our critical technology. This enables health systems to turn what was once considered 'lost' value into a powerful engine for pharmacy innovation." Key Benefits of the Partnership: Through this collaboration, hospitals and health systems can: * Fund software acquisitions and expansions using existing reverse distribution credits rather than relying on new capital budget cycles. * Gain new flexibility in how they plan, prioritize, and deploy technology investments - whether they be core Bluesight technologies or additional product modules. * Quickly evaluate, adopt, and scale technologies that support improved operational efficiency, regulatory compliance, and financial performance. "Pharma Logistics is dedicated to providing full-service return solutions that simplify the lives of pharmacy staff," said David A. Hargraves, CEO at Pharma Logistics. "Our Credit Partner Program combines Pharma Logistics' value recovery efforts with Bluesight's industry-leading software solutions to help hospital pharmacies realize the vision of a tech-enabled future." Since late 2025, health systems across the country have begun adopting Bluesight solutions through this credit-based approach, deploying technology to enhance visibility, strengthen compliance, and improve medication management. About Bluesight Bluesight powers hospital operations with intelligence that simplifies inventory management, procurement, and compliance. Through its suite of industry-leading solutions, Bluesight ensures that health systems protect every patient and optimize every dollar. Over 3,000 United States and Canadian hospitals rely on Bluesight every day to have efficient and safe operations. For more information, please visit bluesight.com. About Pharma Logistics Pharma Logistics is a leader in pharmaceutical reverse distribution, helping healthcare organizations recover maximum value from unused and expired medications while ensuring regulatory compliance. Trusted by more than 12,000 hospitals, pharmacies, and government agencies nationwide, the company combines twice-patented technology, complete line-item visibility, and a dedicated collections team to maximize credit recovery and deliver consistent, measurable financial results. For more information, please visit www.pharmalogistics.com. Related resources. Bluesight expands access to solutions through strategic partnership... Health System Pharmacies Can Leverage Value Uncovered Through Reverse Distribution Services to Purchase Bluesight... How to reduce false positives in privacy monitoring without missing real risk over 305... Beyond the dashboard: how 3 systems are building... Becker's Spring Chief Pharmacy Officer Summit Recap Pharmacy procurement has never been more complex... A practical guide to NDC level contract compliance... Drugmakers raised list prices on more than 350 branded medications at the start of... How RFID supports a more efficient supply chain. Margins are tighter, drug shortages are more frequent, and medication waste from expirations continues... Previous slide Next slide